In Orai3-overexpressing breast cancer cells, NEDD4L mediates the ubiquitination and degradation of its target proteins (including either p53 regulators or p53), inducing chemotherapy resistance (Hasna et al., 2018). This evidence concerns the gene ORAI3 and breast cancer.